Yourway and Firma partner on process delivery for virtual trials

12th May 2020 (Last Updated May 12th, 2020 15:55)

Integrated premium courier and clinical packager Yourway and patient-centric home healthcare provider Firma Clinical Research have partnered to provide coordinated supply and product deliveries, as well as administration services for virtual and decentralised clinical trials.

Yourway and Firma partner on process delivery for virtual trials
The collaboration between Yourway and Firma extends until this year. Credit: Darko Stojanovic from Pixabay.

Integrated premium courier and clinical packager Yourway and patient-centric home healthcare provider Firma Clinical Research have partnered to provide coordinated supply and product deliveries, as well as administration services for virtual and decentralised clinical trials.

The strategic collaboration is aimed at patient retention and compliance, while also helping contract research organisations (CROs) and sponsors improve clinical trial management efficiency.

Yourway president Gulam Jaffer said: “Yourway has served the biopharma industry for more than two decades, and we are proud to collaborate with Firma Clinical to help improve the patient experience for in-home health visits for clinical trials.

“We offer direct-to-patient and direct-from-patient services globally, including shipments that require ambient to frozen temperatures and controlled substances. These services are making virtual and decentralised clinical trials possible.”

Under the partnership, the two companies are working towards a seamless process for coordinated supply delivery and drugs needed for in-home health visits to patients.

According to Yourway, both clinical products and equipment are coordinated to be sent directly to the patient seeking for in-home health visits.

Collected bodily samples and other materials are shipped from the patient’s home via a courier.

This patient-centric approach assures delivery, protocol compliance, and helps maintains data quality.

Firma Clinical Research CEO Michael Woods said: “Firma is committed to the needs of patients, sponsors and healthcare professionals by providing in-home care for clinical trials that often involve investigational products (IP).

“Firma has completed thousands of home health visits in 45 countries, and about 40% include the administration of IPs. We take a patient-centric approach to our services and often work with advocacy groups to collect patient survey data for sponsors.”